{"id":407281,"date":"2021-01-04T07:03:36","date_gmt":"2021-01-04T12:03:36","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407281"},"modified":"2021-01-04T07:03:36","modified_gmt":"2021-01-04T12:03:36","slug":"acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/","title":{"rendered":"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021"},"content":{"rendered":"

<\/p>\n

Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021<\/b><\/p>\n

CAMBRIDGE, Mass.–(BUSINESS WIRE<\/a>)–
\nAcceleron Pharma Inc. (Nasdaq:XLRN) today announced that Habib Dable, Acceleron\u2019s President and Chief Executive Officer, will present a corporate overview during the 39th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 11 at 10:00 a.m. EST, in a virtual format.\n<\/p>\n

\nA live webcast of the presentation will be accessible under \u201cEvents and Presentations\u201d in the Investors & Media page of the Company’s website at www.acceleronpharma.com<\/a>. A replay of the webcast will be available following the event on the Acceleron website.\n<\/p>\n

About Acceleron <\/b><\/p>\n

\nAcceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron\u2019s leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body’s ability to regulate cellular growth and repair.\n<\/p>\n

\nAcceleron focuses its research, development, and commercialization efforts in pulmonary and hematologic diseases. In pulmonary, Acceleron is developing sotatercept for the treatment of pulmonary arterial hypertension (PAH), having reported positive topline results of the PULSAR Phase 2 trial. The Company is currently planning multiple Phase 3 trials with the potential to support its long-term vision of establishing sotatercept as a backbone therapy for patients with PAH at all stages of the disease. Acceleron is also investigating the potential of its early-stage pulmonary candidate, ACE-1334, which it plans to advance into a Phase 1b\/2 trial in systemic sclerosis-associated interstitial lung disease (SSc-ILD) this year.\n<\/p>\n

\nIn hematology, REBLOZYL\u00ae<\/sup> (luspatercept-aamt) is the first and only erythroid maturation agent approved in the United States, Europe, and Canada for the treatment of anemia in certain blood disorders. REBLOZYL is part of a global collaboration partnership with Bristol Myers Squibb. The Companies co-promote REBLOZYL in the United States and are also developing luspatercept for the treatment of anemia in patient populations of myelodysplastic syndromes, beta-thalassemia, and myelofibrosis.\n<\/p>\n

\nFor more information, please visit www.acceleronpharma.com<\/a>. Follow Acceleron on Social Media: @AcceleronPharma<\/a> and LinkedIn<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210104005036\/en\/<\/a><\/span><\/p>\n

\nInvestors:
\n
Jamie Bernard, IRC, 617-301-9650
\n
Associate Director, Investor Relations\n<\/p>\n

\nMedia:
\n
Matt Fearer, 617-301-9557
\n
Director, Corporate Communications\n<\/p>\n

KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Other Health Other Science Research Science Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 CAMBRIDGE, Mass.–(BUSINESS WIRE)– Acceleron Pharma Inc. (Nasdaq:XLRN) today announced that Habib Dable, Acceleron\u2019s President and Chief Executive Officer, will present a corporate overview during the 39th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 11 at 10:00 a.m. EST, in a virtual format. A live webcast of the presentation will be accessible under \u201cEvents and Presentations\u201d in the Investors & Media page of the Company’s website at www.acceleronpharma.com. A replay of the webcast will be available following the event on the Acceleron website. About Acceleron Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to … <\/p>\n

Continue reading “Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-407281","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAcceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 CAMBRIDGE, Mass.–(BUSINESS WIRE)– Acceleron Pharma Inc. (Nasdaq:XLRN) today announced that Habib Dable, Acceleron\u2019s President and Chief Executive Officer, will present a corporate overview during the 39th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 11 at 10:00 a.m. EST, in a virtual format. A live webcast of the presentation will be accessible under \u201cEvents and Presentations\u201d in the Investors & Media page of the Company’s website at www.acceleronpharma.com. A replay of the webcast will be available following the event on the Acceleron website. About Acceleron Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to … Continue reading "Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T12:03:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021\",\"datePublished\":\"2021-01-04T12:03:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/\"},\"wordCount\":407,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/\",\"name\":\"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-01-04T12:03:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/","og_locale":"en_US","og_type":"article","og_title":"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 - Market Newsdesk","og_description":"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 CAMBRIDGE, Mass.–(BUSINESS WIRE)– Acceleron Pharma Inc. (Nasdaq:XLRN) today announced that Habib Dable, Acceleron\u2019s President and Chief Executive Officer, will present a corporate overview during the 39th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 11 at 10:00 a.m. EST, in a virtual format. A live webcast of the presentation will be accessible under \u201cEvents and Presentations\u201d in the Investors & Media page of the Company’s website at www.acceleronpharma.com. A replay of the webcast will be available following the event on the Acceleron website. About Acceleron Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to … Continue reading \"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-04T12:03:36+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021","datePublished":"2021-01-04T12:03:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/"},"wordCount":407,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/","name":"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-01-04T12:03:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210104005036r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/acceleron-to-participate-in-the-39th-annual-j-p-morgan-healthcare-conference-on-january-11-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=407281"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407281\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=407281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=407281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=407281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}